Sort
261,768 grants matching “gene therapy”
Use Of Animal Models To Study Genes That Modulate Atherosclerosis
$1,262,578Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020
$1,262,498Elias Sayour · University Of Florida · R01 · FY2022 · FD
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
$1,262,369Hans-Willem E Snoeck · Columbia University Health Sciences · U01 · FY2018 · HL
Preclinical Mouse Models of Thyroid Cancer
$1,261,890Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$1,261,829Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Small molecule regulation of endogenous transcription factors for circuit-specific neuromodulation
$1,261,798Gerald R. Crabtree · Stanford University · RF1 · FY2021 · MH
RNAi FOR DOMINANT NEUROLOGICAL DISEASE PO1
$1,261,697Beverly L Davidson · University Of Iowa · P01 · FY2006 · NS
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network
$1,261,638Brendan Hl Lee · Baylor College Of Medicine · U54 · FY2015 · AR
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network
$1,261,485Brendan Hl Lee · Baylor College Of Medicine · U54 · FY2017 · AR
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network
$1,261,485Brendan Hl Lee · Baylor College Of Medicine · U54 · FY2016 · AR
Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1
$1,261,293Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Pathogenesis of Tick-Borne Flavivirus Infections
$1,261,052Marshall Bloom · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
$1,261,011Hans-Willem E Snoeck · Columbia University Health Sciences · U01 · FY2019 · HL
Clinical Trial Readiness for SCA1 and SCA3
$1,260,926Tetsuo Ashizawa · Methodist Hospital Research Institute · U01 · FY2018 · NS
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis
$1,260,831Douglas A Marchuk · Duke University · P01 · FY2019 · NS
Project 3: Intraarticular Mineralization
$1,260,794Tuhina Neogi · Boston University Medical Campus · U19 · FY2025 · AG
Novel Strategies for Brain Tumor Therapy
$1,260,789University Of Pittsburgh At Pittsburgh · P01 · FY2002 · NS
Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
$1,260,778Smriti Mehra · Texas Biomedical Research Institute · R01 · FY2022 · AI
Molecular Mechanisms of HIV Latency
$1,260,763Eric M Verdin · Buck Institute For Research On Aging · R01 · FY2021 · DA
Molecular Mechanisms of HIV Latency
$1,260,763Eric M Verdin · Buck Institute For Research On Aging · R01 · FY2020 · DA
Genetics and pathophysiology of systemic juvenile idiopathic arthritis and other complex autoinflammatory diseases
$1,260,744Michael Ombrello · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
$1,260,626Steven Hou · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Gene Therapy Clinical Trials for X-linked Severe Combined Immunodeficiency
$1,260,535Suk De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Molecular Genetics Of Heritable Human Disorders
$1,260,469Janice Chou · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
Predictors of Pregnancy Outcome In SLE and APS
$1,260,461Jane E Salmon · Hospital For Special Surgery · R01 · FY2010 · AR